However, KAT6A mRNA levels are increased in glioblastoma samples compared to normal brain tissue, and KAT6A and has been shown to promote glioma cell proliferation via upregulation of PIK3CA expression and subsequent activation of PI3K/Akt signaling [45]. The gene discussed is AKT1; the disease is central nervous system cancer.